Last update 29 Nov 2025

PHOTAC-I-9

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
PHOTAC-I-9
Target
BRD2 x BRD3 x BRD4
Action
degraders
Mechanism
BRD2 degraders(Bromodomain-containing protein 2 degraders), BRD3 degraders(Bromodomain-containing protein 3 degraders), BRD4 degraders(Bromodomain-containing protein 4 degraders)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
New York UniversityNew York UniversityLudwig-Maximilians-Universität MünchenLudwig-Maximilians-Universität München
Active Organization-
Inactive Organization
Ludwig-Maximilians-Universität MünchenLudwig-Maximilians-Universität MünchenNew York UniversityNew York University
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC44H41ClN10O9S
InChIKeyHGQKJAWOXDNILQ-QUVRRSHZSA-N
CAS Registry-

Related

100 Clinical Results associated with PHOTAC-I-9
Login to view more data
100 Translational Medicine associated with PHOTAC-I-9
Login to view more data
100 Patents (Medical) associated with PHOTAC-I-9
Login to view more data
1
Literatures (Medical) associated with PHOTAC-I-9
21 Feb 2020Science advances
PHOTACs enable optical control of protein degradation
100 Deals associated with PHOTAC-I-9
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
New York UniversityNew York University
21 Feb 2020
NeoplasmsPreclinical
Germany
Ludwig-Maximilians-Universität MünchenLudwig-Maximilians-Universität München
21 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free